Q2 2023 · —
Revenue—
Net Income-$5.52M-$5.52M no prior Q2 2022 on fileN/M vs Q1 2023
EPS Diluted-$3.88-$3.88 no prior Q2 2022 on fileno prior Q1 2023 on file
Operating Income-$5,584,419—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2022 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actuate Therapeutics, Inc. · CIK 1652935 · Engraved from SEC EDGAR